Skip to main content

Advertisement

Log in

An Inverse Correlation of Human Peripheral Blood Regulatory T Cell Frequency with the Disease Activity of Ulcerative Colitis

  • Inflammatory Bowel Disease
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Evidence suggests that CD4+CD25+ regulatory T cells play a crucial role in the suppression of intestinal inflammation. However, their role in the suppression of inflammatory bowel disease has not yet been addressed. We examined the proportion of regulatory T cells in inflammatory bowel disease. First, we isolated CD4+CD45RO+CD25+ T cells from the peripheral blood of healthy persons and showed that these cells suppressed T cell proliferation profoundly and expressed FoxP3 abundantly, revealing that they are regulatory cells. Then the proportion of CD45RO+CD25+ in peripheral blood CD4+ T cells was analyzed in patients and healthy controls by flow cytometry. CD4+CD45RO+CD25+ T cell frequency was significantly lower in active ulcerative colitis than in the control and inactive ulcerative colitis. CD4+CD45RO+CD25+ T cell frequency was inversely correlated with the clinical and endoscopic severity of ulcerative colitis. These results suggest that a deficiency of regulatory T cells is associated with the progression of ulcerative colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205, 1998

    Article  CAS  PubMed  Google Scholar 

  2. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521–533, 2003

    Article  CAS  PubMed  Google Scholar 

  3. Strober W, Nakamura K, Kitani A: The SAMP/1/it mouse: another step closer to modeling human inflammatory bowel disease. J Clin Invest 107:667–670, 2001

    CAS  PubMed  Google Scholar 

  4. Asano M, Toda M, Sakaguchi N, Sakaguchi S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184:387–396, 1996

    Article  CAS  PubMed  Google Scholar 

  5. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S: Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergi/c/uppressive state. Int Immuol 10:1969–1980, 1998

    CAS  Google Scholar 

  6. Thornton AM, Shevach EM: CD25+CD4+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287–296, 1998

    Article  CAS  PubMed  Google Scholar 

  7. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562, 2004

    Article  CAS  PubMed  Google Scholar 

  8. Shevach EM: CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2:389–400, 2002

    CAS  PubMed  Google Scholar 

  9. Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 192:295–302, 2000

    Article  CAS  PubMed  Google Scholar 

  10. Mottet C, Ublig HH, Powrie F: Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170:3939–3943, 2003

    CAS  PubMed  Google Scholar 

  11. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S: Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162:5317–5326, 1999

    CAS  PubMed  Google Scholar 

  12. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294, 2001

    Article  CAS  PubMed  Google Scholar 

  13. Levings MK, Sangregorio R, Roncarolo MG: Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295–1301, 2001

    Article  CAS  PubMed  Google Scholar 

  14. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med 193:1303–1310, 2001

    Article  CAS  PubMed  Google Scholar 

  15. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167:1245–1253, 2001

    CAS  PubMed  Google Scholar 

  16. Taylor PA, Lees CJ, Blazar BR: The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493–3499, 2002

    CAS  PubMed  Google Scholar 

  17. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA: B/7/D28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440, 2000

    Article  CAS  PubMed  Google Scholar 

  18. Liu MF, Wang CR, Fung LL, Wu CR: Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59:198–202, 2004

    Article  PubMed  Google Scholar 

  19. de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B: CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443, 2004

    PubMed  Google Scholar 

  20. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C: Isolation and function characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215–223, 2003

    Article  CAS  PubMed  Google Scholar 

  21. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971–979, 2004

    Article  CAS  PubMed  Google Scholar 

  22. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR: Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 16:1–9, 2001

    Article  CAS  PubMed  Google Scholar 

  23. Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, ABBY S, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I: Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 1:28–35, 2003

    Article  PubMed  Google Scholar 

  24. Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis:a randomized trial. Br Med J 298:82–86, 1989

    CAS  Google Scholar 

  25. Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, Nakamura T, Koganei K, Fukushima T, Watanabe M: CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 173:3119–3130, 2004

    CAS  PubMed  Google Scholar 

  26. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W: TGF–Β1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172:834–842, 2004

    CAS  PubMed  Google Scholar 

  27. Taams LS, Vukkmannovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JWJ, Lafeber FPJG, Salmon M, Akbar AN: Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 32:1621–1630, 2002

    Article  CAS  PubMed  Google Scholar 

  28. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor FoxP3. Science 299:1057–1061, 2003

    Article  CAS  PubMed  Google Scholar 

  29. Fontenot JD, Gavin MA, Rudensky AY: FoxP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336, 2003

    Article  CAS  PubMed  Google Scholar 

  30. Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337–342, 2003

    Article  CAS  PubMed  Google Scholar 

  31. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106:75–81, 2000

    Google Scholar 

  32. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18–20, 2001

    Article  CAS  PubMed  Google Scholar 

  33. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhea/d/inged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27:68–73, 2001

    Article  CAS  PubMed  Google Scholar 

  34. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, Sakaguchi S: Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16:1643–1656, 2004

    Article  CAS  PubMed  Google Scholar 

  35. Asseman C, Mauze S, Leach MW Coffman RL, Powrie F: An essential role for Interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995–1004, 1999

    Article  CAS  PubMed  Google Scholar 

  36. Nakamura K, Kiani A, Strober W: Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor Β. J Exp Med 194:629–644, 2001

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuhiko Nakamura MD, PhD.

Additional information

This work was supported in part by Health and Labour Science Research Grants from the Japanese Ministry of Health, Labour and Welfare and Research on Measures for Intractable Disease.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, M., Nakamura, K., Honda, K. et al. An Inverse Correlation of Human Peripheral Blood Regulatory T Cell Frequency with the Disease Activity of Ulcerative Colitis. Dig Dis Sci 51, 677–686 (2006). https://doi.org/10.1007/s10620-006-3191-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-3191-2

Key Words

Navigation